CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Swathi Srikantan, Xuan Ma, Asif Alavi, Josephine Emole, Edward M. Peres, Muneer H. Abidi, Shatha Farhan

DOI: 10.1016/j.jtct.2025.12.692

Cited by: 1

Fields of Study & Subjects

Chemokine receptors and signaling Hematopoietic Stem Cell Transplantation T-cell and B-cell Immunology